EMEA (Europe, Middle East and Africa) Flu Vaccine Market Report 2017
This report studies the Flu Vaccine market status and outlook of EMEA and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in EMEA and major countries, and splits the Flu Vaccine market by product type and applications/end industries.
In the last several years, the EMEA (Europe, Middle East and Africa) market of Flu Vaccine developed rapidly, with an average growth rate of 7.50%. In 2016, EMEA (Europe, Middle East and Africa) Revenue of Flu Vaccine is nearly 750 M USD; the actual sales are about 77 M Doses.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Flu Vaccine in these regions, from 2012 to 2022 (forecast), covering
Europe covers Germany, France, UK, Russia, Italy and Benelux;
Middle East includes Saudi Arabia, Israel, UAE and Iran;
Africa includes South Africa, Nigeria, Egypt and Algeria.
The major players/manufacturers in EMEA market include
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
On the basis of product, the Flu Vaccine market is primarily split into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
On the basis on the end users/applications, this report covers
For Children (6 months to 3 years)
For Adults and Children over 3 years
In the last several years, the EMEA (Europe, Middle East and Africa) market of Flu Vaccine developed rapidly, with an average growth rate of 7.50%. In 2016, EMEA (Europe, Middle East and Africa) Revenue of Flu Vaccine is nearly 750 M USD; the actual sales are about 77 M Doses.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Flu Vaccine in these regions, from 2012 to 2022 (forecast), covering
Europe covers Germany, France, UK, Russia, Italy and Benelux;
Middle East includes Saudi Arabia, Israel, UAE and Iran;
Africa includes South Africa, Nigeria, Egypt and Algeria.
The major players/manufacturers in EMEA market include
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
On the basis of product, the Flu Vaccine market is primarily split into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
On the basis on the end users/applications, this report covers
For Children (6 months to 3 years)
For Adults and Children over 3 years
1 FLU VACCINE OVERVIEW
1.1 Product Overview and Scope of Flu Vaccine
1.2 Classification of Flu Vaccine by Product Category
1.2.1 EMEA Flu Vaccine Sales Market Share by Types in 2016
1.2.2 Whole Virus Vaccines
1.2.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.2.5 Live Attenuated Virus Vaccines
1.3 EMEA Flu Vaccine Market by Applications/End Users
1.3.1 EMEA Flu Vaccine Sales Market Share by Applications (2012-2022)
1.3.2 For Children (6 months to 3 years old)
1.3.3 For Adult and Children over 3 years
1.4 EMEA Flu Vaccine Market Overview by Regions
1.4.1 EMEA Flu Vaccine Revenue Comparison by Regions (2012-2022)
1.4.2 Europe Flu Vaccine Status and Prospect (2012-2022)
1.4.3 Middle East Flu Vaccine Status and Prospect (2012-2022)
1.4.4 Africa Flu Vaccine Status and Prospect (2012-2022)
1.5 EMEA Market Size (Sales and Revenue) of Flu Vaccine (2012-2022)
1.5.1 EMEA Flu Vaccine Sales and Growth Rate (2012-2022)
1.5.2 EMEA Flu Vaccine Revenue and Growth Rate (2012-2022)
2 EMEA FLU VACCINE COMPETITION BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION
2.1 EMEA Flu Vaccine Market Competition by Manufacturers
2.1.1 EMEA Flu Vaccine Sales and Market Share of Major Players (2016-2017)
2.1.2 EMEA Flu Vaccine Revenue and Market Share by Manufacturers (2016-2017)
2.1.3 EMEA Flu Vaccine Sale Price by Manufacturers (2016-2017)
2.2 EMEA Flu Vaccine Sales and Revenue by Type
2.2.1 EMEA Flu Vaccine Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Flu Vaccine Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Flu Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Flu Vaccine (Volume) by Application
2.4 EMEA Flu Vaccine Sales and Revenue by Regions
2.4.1 EMEA Flu Vaccine Sales and Market Share by Regions (2012-2017)
2.4.2 EMEA Flu Vaccine Revenue and Market Share by Regions (2012-2017)
2.4.3 EMEA Flu Vaccine Sales Price by Regions (2012-2017)
3 EUROPE FLU VACCINE (SALES, REVENUE AND PRICE), BY COUNTRIES, TYPE AND APPLICATION
3.1 Europe Flu Vaccine Sales and Revenue (2012-2017)
3.1.1 Europe Flu Vaccine Sales and Growth Rate (2012-2017)
3.1.2 Europe Flu Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Flu Vaccine Sales and Market Share by Type
3.3 Europe Flu Vaccine Sales and Market Share by Applications
3.4 Europe Flu Vaccine Sales and Revenue by Countries
3.4.1 Europe Flu Vaccine Sales by Countries (2012-2017)
3.4.2 Europe Flu Vaccine Revenue by Countries (2012-2017)
3.4.3 Germany Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.4 France Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.5 UK Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.6 Russia Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.7 Italy Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.8 Benelux Flu Vaccine Sales and Growth Rate (2012-2017)
4 MIDDLE EAST FLU VACCINE (SALES, REVENUE AND PRICE), BY COUNTRIES, TYPE AND APPLICATION
4.1 Middle East Flu Vaccine Sales and Revenue (2012-2017)
4.1.1 Middle East Flu Vaccine Sales and Growth Rate (2012-2017)
4.1.2 Middle East Flu Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Flu Vaccine Sales and Market Share by Type
4.3 Middle East Flu Vaccine Sales and Market Share by Applications
4.4 Middle East Flu Vaccine Sales and Revenue by Countries (2012-2017)
4.4.1 Middle East Flu Vaccine Sales by Countries (2012-2017)
4.4.2 Middle East Flu Vaccine Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Flu Vaccine Sales and Growth Rate (2012-2017)
4.4.4 Israel Flu Vaccine Sales and Growth Rate (2012-2017)
4.4.5 UAE Flu Vaccine Sales and Growth Rate (2012-2017)
4.4.6 Iran Flu Vaccine Sales and Growth Rate (2012-2017)
5 AFRICA FLU VACCINE (SALES, REVENUE AND PRICE), BY COUNTRIES, TYPE AND APPLICATION
5.1 Africa Flu Vaccine Sales and Revenue (2012-2017)
5.1.1 Africa Flu Vaccine Sales and Growth Rate (2012-2017)
5.1.2 Africa Flu Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Flu Vaccine Sales and Market Share by Type
5.3 Africa Flu Vaccine Sales and Market Share by Applications
5.4 Africa Flu Vaccine Sales and Revenue by Countries (2012-2017)
5.4.1 Africa Flu Vaccine Sales by Countries (2012-2017)
5.4.2 Africa Flu Vaccine Revenue by Countries (2012-2017)
5.4.3 South Africa Flu Vaccine Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Flu Vaccine Sales and Growth Rate (2012-2017)
5.4.5 Egypt Flu Vaccine Sales and Growth Rate (2012-2017)
5.4.6 Algeria Flu Vaccine Sales and Growth Rate (2012-2017)
6 ANALYSIS OF FLU VACCINE INDUSTRY KEY MANUFACTURERS
6.1 CSL
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Sales, Price, Revenue and Gross Margin
6.2 GSK
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Sales, Price, Revenue and Gross Margin
6.3 Sanofi Pasteur
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Sales, Price, Revenue and Gross Margin
6.4 Mylan
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Sales, Price, Revenue and Gross Margin
6.5 AstraZeneca
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Sales, Price, Revenue and Gross Margin
6.6 Pfizer
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Sales, Price, Revenue and Gross Margin
6.7 Johnson & Johnson
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Sales, Price, Revenue and Gross Margin
7 FLU VACCINE MANUFACTURING COST ANALYSIS
7.1 Flu Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Other Costs Analysis
7.3 Manufacturing Process Analysis of Flu Vaccine
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Flu Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA FLU VACCINE MARKET FORECAST (2017-2022)
11.1 EMEA Flu Vaccine Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Flu Vaccine Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Flu Vaccine Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Flu Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Flu Vaccine Sales and Revenue and Growth Rate Forecast by Regions (2017-2022)
11.3 Europe Flu Vaccine Sales and Revenue and Growth Rate Forecast by Regions (2017-2022)
11.4 Middle East Flu Vaccine Sales and Revenue and Growth Rate Forecast by Regions (2017-2022)
11.5 Africa Flu Vaccine Sales and Revenue and Growth Rate Forecast by Regions (2017-2022)
11.6 EMEA Flu Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Flu Vaccine Sales Forecast by Application (2017-2022)
12 RESEARCH FINDINGS AND CONCLUSION
13 METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1.1 Product Overview and Scope of Flu Vaccine
1.2 Classification of Flu Vaccine by Product Category
1.2.1 EMEA Flu Vaccine Sales Market Share by Types in 2016
1.2.2 Whole Virus Vaccines
1.2.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.2.5 Live Attenuated Virus Vaccines
1.3 EMEA Flu Vaccine Market by Applications/End Users
1.3.1 EMEA Flu Vaccine Sales Market Share by Applications (2012-2022)
1.3.2 For Children (6 months to 3 years old)
1.3.3 For Adult and Children over 3 years
1.4 EMEA Flu Vaccine Market Overview by Regions
1.4.1 EMEA Flu Vaccine Revenue Comparison by Regions (2012-2022)
1.4.2 Europe Flu Vaccine Status and Prospect (2012-2022)
1.4.3 Middle East Flu Vaccine Status and Prospect (2012-2022)
1.4.4 Africa Flu Vaccine Status and Prospect (2012-2022)
1.5 EMEA Market Size (Sales and Revenue) of Flu Vaccine (2012-2022)
1.5.1 EMEA Flu Vaccine Sales and Growth Rate (2012-2022)
1.5.2 EMEA Flu Vaccine Revenue and Growth Rate (2012-2022)
2 EMEA FLU VACCINE COMPETITION BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION
2.1 EMEA Flu Vaccine Market Competition by Manufacturers
2.1.1 EMEA Flu Vaccine Sales and Market Share of Major Players (2016-2017)
2.1.2 EMEA Flu Vaccine Revenue and Market Share by Manufacturers (2016-2017)
2.1.3 EMEA Flu Vaccine Sale Price by Manufacturers (2016-2017)
2.2 EMEA Flu Vaccine Sales and Revenue by Type
2.2.1 EMEA Flu Vaccine Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Flu Vaccine Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Flu Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Flu Vaccine (Volume) by Application
2.4 EMEA Flu Vaccine Sales and Revenue by Regions
2.4.1 EMEA Flu Vaccine Sales and Market Share by Regions (2012-2017)
2.4.2 EMEA Flu Vaccine Revenue and Market Share by Regions (2012-2017)
2.4.3 EMEA Flu Vaccine Sales Price by Regions (2012-2017)
3 EUROPE FLU VACCINE (SALES, REVENUE AND PRICE), BY COUNTRIES, TYPE AND APPLICATION
3.1 Europe Flu Vaccine Sales and Revenue (2012-2017)
3.1.1 Europe Flu Vaccine Sales and Growth Rate (2012-2017)
3.1.2 Europe Flu Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Flu Vaccine Sales and Market Share by Type
3.3 Europe Flu Vaccine Sales and Market Share by Applications
3.4 Europe Flu Vaccine Sales and Revenue by Countries
3.4.1 Europe Flu Vaccine Sales by Countries (2012-2017)
3.4.2 Europe Flu Vaccine Revenue by Countries (2012-2017)
3.4.3 Germany Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.4 France Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.5 UK Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.6 Russia Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.7 Italy Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.8 Benelux Flu Vaccine Sales and Growth Rate (2012-2017)
4 MIDDLE EAST FLU VACCINE (SALES, REVENUE AND PRICE), BY COUNTRIES, TYPE AND APPLICATION
4.1 Middle East Flu Vaccine Sales and Revenue (2012-2017)
4.1.1 Middle East Flu Vaccine Sales and Growth Rate (2012-2017)
4.1.2 Middle East Flu Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Flu Vaccine Sales and Market Share by Type
4.3 Middle East Flu Vaccine Sales and Market Share by Applications
4.4 Middle East Flu Vaccine Sales and Revenue by Countries (2012-2017)
4.4.1 Middle East Flu Vaccine Sales by Countries (2012-2017)
4.4.2 Middle East Flu Vaccine Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Flu Vaccine Sales and Growth Rate (2012-2017)
4.4.4 Israel Flu Vaccine Sales and Growth Rate (2012-2017)
4.4.5 UAE Flu Vaccine Sales and Growth Rate (2012-2017)
4.4.6 Iran Flu Vaccine Sales and Growth Rate (2012-2017)
5 AFRICA FLU VACCINE (SALES, REVENUE AND PRICE), BY COUNTRIES, TYPE AND APPLICATION
5.1 Africa Flu Vaccine Sales and Revenue (2012-2017)
5.1.1 Africa Flu Vaccine Sales and Growth Rate (2012-2017)
5.1.2 Africa Flu Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Flu Vaccine Sales and Market Share by Type
5.3 Africa Flu Vaccine Sales and Market Share by Applications
5.4 Africa Flu Vaccine Sales and Revenue by Countries (2012-2017)
5.4.1 Africa Flu Vaccine Sales by Countries (2012-2017)
5.4.2 Africa Flu Vaccine Revenue by Countries (2012-2017)
5.4.3 South Africa Flu Vaccine Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Flu Vaccine Sales and Growth Rate (2012-2017)
5.4.5 Egypt Flu Vaccine Sales and Growth Rate (2012-2017)
5.4.6 Algeria Flu Vaccine Sales and Growth Rate (2012-2017)
6 ANALYSIS OF FLU VACCINE INDUSTRY KEY MANUFACTURERS
6.1 CSL
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Sales, Price, Revenue and Gross Margin
6.2 GSK
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Sales, Price, Revenue and Gross Margin
6.3 Sanofi Pasteur
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Sales, Price, Revenue and Gross Margin
6.4 Mylan
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Sales, Price, Revenue and Gross Margin
6.5 AstraZeneca
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Sales, Price, Revenue and Gross Margin
6.6 Pfizer
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Sales, Price, Revenue and Gross Margin
6.7 Johnson & Johnson
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Sales, Price, Revenue and Gross Margin
7 FLU VACCINE MANUFACTURING COST ANALYSIS
7.1 Flu Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Other Costs Analysis
7.3 Manufacturing Process Analysis of Flu Vaccine
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Flu Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA FLU VACCINE MARKET FORECAST (2017-2022)
11.1 EMEA Flu Vaccine Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Flu Vaccine Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Flu Vaccine Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Flu Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Flu Vaccine Sales and Revenue and Growth Rate Forecast by Regions (2017-2022)
11.3 Europe Flu Vaccine Sales and Revenue and Growth Rate Forecast by Regions (2017-2022)
11.4 Middle East Flu Vaccine Sales and Revenue and Growth Rate Forecast by Regions (2017-2022)
11.5 Africa Flu Vaccine Sales and Revenue and Growth Rate Forecast by Regions (2017-2022)
11.6 EMEA Flu Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Flu Vaccine Sales Forecast by Application (2017-2022)
12 RESEARCH FINDINGS AND CONCLUSION
13 METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Product Picture of Flu Vaccine
Table Classification of Flu Vaccine
Figure EMEA Flu Vaccine Sales Market Share by Types in 2016
Figure Whole Virus Vaccines Product Picture
Figure Split Virus Vaccines Product Picture
Figure Subunit Vaccines Picture
Figure Live Attenuated Virus Vaccines Picture
Table Applications of Flu Vaccine
Figure EMEA Sales Market Share of Flu Vaccine by Applications in 2016
Figure For Children (6 months to 3 years old) Examples
Figure For Adult and Children over 3 years Examples
Table EMEA Market Flu Vaccine Revenue (M USD) Comparison by Regions 2012-2022
Figure Europe Flu Vaccine Revenue (M USD) and Growth Rate (2012-2022)
Figure Middle East Flu Vaccine Revenue (M USD) and Growth Rate (2012-2022)
Figure Africa Flu Vaccine Revenue (M USD) and Growth Rate (2012-2022)
Figure EMEA Flu Vaccine Sales (K Doses) and Growth Rate (2012-2022)
Figure EMEA Flu Vaccine Revenue (M USD) and Growth Rate (2012-2022)
Table EMEA Flu Vaccine Sales (K Doses) of Major Manufacturers (2016-2017)
Table EMEA Flu Vaccine Sales Market Share by Manufacturers (2016-2017)
Figure 2016 Flu Vaccine Sales Market Share by Manufacturers
Figure 2017 Flu Vaccine Sales Market Share by Manufacturers
Table EMEA Flu Vaccine Revenue (M USD) by Manufacturers (2016-2017)
Table EMEA Flu Vaccine Revenue Market Share by Manufacturers (2016-2017)
Table 2016 EMEA Flu Vaccine Revenue Market Share by Manufacturers
Table 2017 EMEA Flu Vaccine Revenue Market Share by Manufacturers
Table EMEA Flu Vaccine Sale Price (USD/Doses) by Manufacturers (2016-2017)
Table EMEA Flu Vaccine Sales (K Doses) by Type (2012-2017)
Table EMEA Flu Vaccine Sales Market Share by Type (2012-2017)
Figure Sales Market Share of Flu Vaccine by Type (2012-2017)
Figure EMEA Flu Vaccine Sales Market Share by Type in 2016
Table EMEA Flu Vaccine Revenue (M USD) and Market Share by Type (2012-2017)
Table EMEA Flu Vaccine Revenue Market Share by Type (2012-2017)
Figure Revenue Market Share of Flu Vaccine by Type in 2016
Table EMEA Flu Vaccine Sale Price (USD/Doses) by Type (2012-2017)
Table EMEA Flu Vaccine Sales (K Doses) and Market Share by Application (2012-2017)
Table EMEA Flu Vaccine Sales Market Share by Application (2012-2017)
Figure Sales Market Share of Flu Vaccine by Application (2012-2017)
Figure EMEA Flu Vaccine Sales Market Share by Application in 2016
Table EMEA Flu Vaccine Sales (K Doses) by Regions (2012-2017)
Table EMEA Flu Vaccine Sales Market Share by Regions (2012-2017)
Figure Sales Market Share of Flu Vaccine by Regions (2012-2017)
Figure EMEA Flu Vaccine Sales Market Share in 2016
Table EMEA Flu Vaccine Revenue (M USD) and Market Share by Regions (2012-2017)
Table EMEA Flu Vaccine Revenue Market Share by Regions (2012-2017)
Figure Revenue Market Share of Flu Vaccine by Regions (2012-2017)
Figure EMEA Flu Vaccine Revenue Market Share Regions in 2016
Table EMEA Flu Vaccine Sales Price (USD/Doses) by Regions (2012-2017)
Figure Europe Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Europe Flu Vaccine Revenue (M USD) and Growth Rate (2012-2017)
Table Europe Flu Vaccine Sales by Type (2012-2017)
Table Europe Flu Vaccine Sales Market Share by Type (2012-2017)
Figure Europe Flu Vaccine Sales Market Share by Type in 2016
Table Europe Flu Vaccine Sales (K Doses) by Applications (2012-2017)
Table Europe Flu Vaccine Market Share by Applications (2012-2017)
Figure Europe Flu Vaccine Market Share by Applications in 2016
Table Europe Flu Vaccine Sales (K Doses) by Countries (2012-2017)
Table Europe Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Sales Market Share by Countries in 2016
Table Europe Flu Vaccine Revenue (M USD) by Countries (2012-2017)
Table Europe Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Revenue Market Share by Countries in 2016
Figure Germany Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure France Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UK Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Russia Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Italy Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Benelux Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Flu Vaccine Revenue (M USD) and Growth Rate (2012-2017)
Table Middle East Flu Vaccine Sales (K Doses) by Type (2012-2017)
Table Middle East Flu Vaccine Market Share by Type (2012-2017)
Figure Middle East Flu Vaccine Market Share by Type (2012-2017)
Table Middle East Flu Vaccine Sales (K Doses) by Applications (2012-2017)
Table Middle East Flu Vaccine Market Share by Applications (2012-2017)
Figure Middle East Flu Vaccine Sales Market Share by Application in 2016
Table Middle East Flu Vaccine Sales (K Doses) by Countries (2012-2017)
Table Middle East Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Middle East Flu Vaccine Sales Market Share by Countries in (2012-2017)
Figure Middle East Flu Vaccine Sales Market Share by Countries in 2016
Table Middle East Flu Vaccine Revenue (M USD) by Countries (2012-2017)
Table Middle East Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Flu Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Israel Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UAE Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Iran Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Flu Vaccine Revenue (M USD) and Growth Rate (2012-2017)
Table Africa Flu Vaccine Sales (K Doses) by Type (2012-2017)
Table Africa Flu Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Type in 2016
Table Africa Flu Vaccine Sales (K Doses) by Applications (2012-2017)
Table Africa Flu Vaccine Sales Market Share by Applications (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Applications (2012-2017)
Table Africa Flu Vaccine Sales (K Doses) by Countries (2012-2017)
Table Africa Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Countries in 2016
Table Africa Flu Vaccine Revenue (M USD) by Countries (2012-2017)
Table Africa Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Nigeria Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Egypt Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Algeria Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Table CSL Company Profile
Figure Flu Vaccine Product Picture of CSL
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of CSL 2016-2017
Table GSK Company Profile
Figure Flu Vaccine Product Picture of GSK
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of GSK 2016-2017
Table Sanofi Pasteur Company Profile
Figure Flu Vaccine Product Picture of Sanofi Pasteur
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of Sanofi Pasteur 2016-2017
Table Mylan Company Profile
Figure Flu Vaccine Product Picture of Mylan
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of Mylan 2016-2017
Table AstraZeneca Company Profile
Figure Flu Vaccine Product Picture of AstraZeneca
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of AstraZeneca 2016-2017
Table Pfizer Company Profile
Figure Flu Vaccine Product Picture of Pfizer
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of Pfizer 2016-2017
Table Johnson & Johnson Company Profile
Figure Flu Vaccine Product Picture of Johnson & Johnson
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of Johnson & Johnson 2016-2017
Table Production Base and Market Concentration Rate of Raw Material
Table Key Suppliers of Raw Materials
Table Manufacturing Cost Structure of Flu Vaccine
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe
Figure Electricity Prices for Household Consumers in 2016
Figure Manufacturing Process Analysis of Flu Vaccine
Figure Flu Vaccine Industrial Chain Analysis
Table Major Buyers of Flu Vaccine
Figure Setting Pricing Policy
Table Distributors/Traders List
Figure Global GDP Map 2016
Figure EU GDP Change 2006-2016
Figure German CPI Change 2016-2017
Figure UK CPI Change 2007-2016
Figure EMEA Flu Vaccine Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Flu Vaccine Revenue (M USD) and Growth Rate Forecast (2017-2022)
Figure EMEA Flu Vaccine Price (USD/Doses) and Trend Forecast (2017-2022)
Table EMEA Flu Vaccine Sales (K Doses) Forecast by Regions (2017-2022)
Figure EMEA Flu Vaccine Sales Market Share Forecast by Regions (2017-2022)
Table EMEA Flu Vaccine Revenue (M USD) Forecast by Regions (2017-2022)
Figure EMEA Flu Vaccine Revenue Market Share Forecast by Regions (2017-2022)
Table Europe Flu Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Europe Flu Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Flu Vaccine Revenue (M USD) Forecast by Countries (2017-2022)
Figure Europe Flu Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Flu Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Middle East Flu Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Flu Vaccine Revenue (M USD) Forecast by Countries (2017-2022)
Figure Middle East Flu Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Flu Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Africa Flu Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Flu Vaccine Revenue (M USD) Forecast by Countries (2017-2022)
Figure Africa Flu Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Flu Vaccine Sales (K Doses) Forecast by Type (2017-2022)
Figure EMEA Flu Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Flu Vaccine Sales (K Doses) Forecast by Application (2017-2022)
Figure EMEA Flu Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Product Picture of Flu Vaccine
Table Classification of Flu Vaccine
Figure EMEA Flu Vaccine Sales Market Share by Types in 2016
Figure Whole Virus Vaccines Product Picture
Figure Split Virus Vaccines Product Picture
Figure Subunit Vaccines Picture
Figure Live Attenuated Virus Vaccines Picture
Table Applications of Flu Vaccine
Figure EMEA Sales Market Share of Flu Vaccine by Applications in 2016
Figure For Children (6 months to 3 years old) Examples
Figure For Adult and Children over 3 years Examples
Table EMEA Market Flu Vaccine Revenue (M USD) Comparison by Regions 2012-2022
Figure Europe Flu Vaccine Revenue (M USD) and Growth Rate (2012-2022)
Figure Middle East Flu Vaccine Revenue (M USD) and Growth Rate (2012-2022)
Figure Africa Flu Vaccine Revenue (M USD) and Growth Rate (2012-2022)
Figure EMEA Flu Vaccine Sales (K Doses) and Growth Rate (2012-2022)
Figure EMEA Flu Vaccine Revenue (M USD) and Growth Rate (2012-2022)
Table EMEA Flu Vaccine Sales (K Doses) of Major Manufacturers (2016-2017)
Table EMEA Flu Vaccine Sales Market Share by Manufacturers (2016-2017)
Figure 2016 Flu Vaccine Sales Market Share by Manufacturers
Figure 2017 Flu Vaccine Sales Market Share by Manufacturers
Table EMEA Flu Vaccine Revenue (M USD) by Manufacturers (2016-2017)
Table EMEA Flu Vaccine Revenue Market Share by Manufacturers (2016-2017)
Table 2016 EMEA Flu Vaccine Revenue Market Share by Manufacturers
Table 2017 EMEA Flu Vaccine Revenue Market Share by Manufacturers
Table EMEA Flu Vaccine Sale Price (USD/Doses) by Manufacturers (2016-2017)
Table EMEA Flu Vaccine Sales (K Doses) by Type (2012-2017)
Table EMEA Flu Vaccine Sales Market Share by Type (2012-2017)
Figure Sales Market Share of Flu Vaccine by Type (2012-2017)
Figure EMEA Flu Vaccine Sales Market Share by Type in 2016
Table EMEA Flu Vaccine Revenue (M USD) and Market Share by Type (2012-2017)
Table EMEA Flu Vaccine Revenue Market Share by Type (2012-2017)
Figure Revenue Market Share of Flu Vaccine by Type in 2016
Table EMEA Flu Vaccine Sale Price (USD/Doses) by Type (2012-2017)
Table EMEA Flu Vaccine Sales (K Doses) and Market Share by Application (2012-2017)
Table EMEA Flu Vaccine Sales Market Share by Application (2012-2017)
Figure Sales Market Share of Flu Vaccine by Application (2012-2017)
Figure EMEA Flu Vaccine Sales Market Share by Application in 2016
Table EMEA Flu Vaccine Sales (K Doses) by Regions (2012-2017)
Table EMEA Flu Vaccine Sales Market Share by Regions (2012-2017)
Figure Sales Market Share of Flu Vaccine by Regions (2012-2017)
Figure EMEA Flu Vaccine Sales Market Share in 2016
Table EMEA Flu Vaccine Revenue (M USD) and Market Share by Regions (2012-2017)
Table EMEA Flu Vaccine Revenue Market Share by Regions (2012-2017)
Figure Revenue Market Share of Flu Vaccine by Regions (2012-2017)
Figure EMEA Flu Vaccine Revenue Market Share Regions in 2016
Table EMEA Flu Vaccine Sales Price (USD/Doses) by Regions (2012-2017)
Figure Europe Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Europe Flu Vaccine Revenue (M USD) and Growth Rate (2012-2017)
Table Europe Flu Vaccine Sales by Type (2012-2017)
Table Europe Flu Vaccine Sales Market Share by Type (2012-2017)
Figure Europe Flu Vaccine Sales Market Share by Type in 2016
Table Europe Flu Vaccine Sales (K Doses) by Applications (2012-2017)
Table Europe Flu Vaccine Market Share by Applications (2012-2017)
Figure Europe Flu Vaccine Market Share by Applications in 2016
Table Europe Flu Vaccine Sales (K Doses) by Countries (2012-2017)
Table Europe Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Sales Market Share by Countries in 2016
Table Europe Flu Vaccine Revenue (M USD) by Countries (2012-2017)
Table Europe Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Revenue Market Share by Countries in 2016
Figure Germany Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure France Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UK Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Russia Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Italy Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Benelux Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Flu Vaccine Revenue (M USD) and Growth Rate (2012-2017)
Table Middle East Flu Vaccine Sales (K Doses) by Type (2012-2017)
Table Middle East Flu Vaccine Market Share by Type (2012-2017)
Figure Middle East Flu Vaccine Market Share by Type (2012-2017)
Table Middle East Flu Vaccine Sales (K Doses) by Applications (2012-2017)
Table Middle East Flu Vaccine Market Share by Applications (2012-2017)
Figure Middle East Flu Vaccine Sales Market Share by Application in 2016
Table Middle East Flu Vaccine Sales (K Doses) by Countries (2012-2017)
Table Middle East Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Middle East Flu Vaccine Sales Market Share by Countries in (2012-2017)
Figure Middle East Flu Vaccine Sales Market Share by Countries in 2016
Table Middle East Flu Vaccine Revenue (M USD) by Countries (2012-2017)
Table Middle East Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Flu Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Israel Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UAE Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Iran Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Flu Vaccine Revenue (M USD) and Growth Rate (2012-2017)
Table Africa Flu Vaccine Sales (K Doses) by Type (2012-2017)
Table Africa Flu Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Type in 2016
Table Africa Flu Vaccine Sales (K Doses) by Applications (2012-2017)
Table Africa Flu Vaccine Sales Market Share by Applications (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Applications (2012-2017)
Table Africa Flu Vaccine Sales (K Doses) by Countries (2012-2017)
Table Africa Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Countries in 2016
Table Africa Flu Vaccine Revenue (M USD) by Countries (2012-2017)
Table Africa Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Nigeria Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Egypt Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Algeria Flu Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Table CSL Company Profile
Figure Flu Vaccine Product Picture of CSL
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of CSL 2016-2017
Table GSK Company Profile
Figure Flu Vaccine Product Picture of GSK
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of GSK 2016-2017
Table Sanofi Pasteur Company Profile
Figure Flu Vaccine Product Picture of Sanofi Pasteur
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of Sanofi Pasteur 2016-2017
Table Mylan Company Profile
Figure Flu Vaccine Product Picture of Mylan
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of Mylan 2016-2017
Table AstraZeneca Company Profile
Figure Flu Vaccine Product Picture of AstraZeneca
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of AstraZeneca 2016-2017
Table Pfizer Company Profile
Figure Flu Vaccine Product Picture of Pfizer
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of Pfizer 2016-2017
Table Johnson & Johnson Company Profile
Figure Flu Vaccine Product Picture of Johnson & Johnson
Table Flu Vaccine Sales (K Doses), Price (USD/Doses), Revenue (M USD) and Gross Margin of Johnson & Johnson 2016-2017
Table Production Base and Market Concentration Rate of Raw Material
Table Key Suppliers of Raw Materials
Table Manufacturing Cost Structure of Flu Vaccine
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe
Figure Electricity Prices for Household Consumers in 2016
Figure Manufacturing Process Analysis of Flu Vaccine
Figure Flu Vaccine Industrial Chain Analysis
Table Major Buyers of Flu Vaccine
Figure Setting Pricing Policy
Table Distributors/Traders List
Figure Global GDP Map 2016
Figure EU GDP Change 2006-2016
Figure German CPI Change 2016-2017
Figure UK CPI Change 2007-2016
Figure EMEA Flu Vaccine Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Flu Vaccine Revenue (M USD) and Growth Rate Forecast (2017-2022)
Figure EMEA Flu Vaccine Price (USD/Doses) and Trend Forecast (2017-2022)
Table EMEA Flu Vaccine Sales (K Doses) Forecast by Regions (2017-2022)
Figure EMEA Flu Vaccine Sales Market Share Forecast by Regions (2017-2022)
Table EMEA Flu Vaccine Revenue (M USD) Forecast by Regions (2017-2022)
Figure EMEA Flu Vaccine Revenue Market Share Forecast by Regions (2017-2022)
Table Europe Flu Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Europe Flu Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Flu Vaccine Revenue (M USD) Forecast by Countries (2017-2022)
Figure Europe Flu Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Flu Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Middle East Flu Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Flu Vaccine Revenue (M USD) Forecast by Countries (2017-2022)
Figure Middle East Flu Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Flu Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Africa Flu Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Flu Vaccine Revenue (M USD) Forecast by Countries (2017-2022)
Figure Africa Flu Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Flu Vaccine Sales (K Doses) Forecast by Type (2017-2022)
Figure EMEA Flu Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Flu Vaccine Sales (K Doses) Forecast by Application (2017-2022)
Figure EMEA Flu Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
